CORD-19:c654596857bce9cdd64ffc51842048643107348c / 414299-414438 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3538","span":{"begin":0,"end":139},"obj":"Sentence"},{"id":"T51738","span":{"begin":0,"end":139},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The positive rates of anti-TTV antibodies were 11.29% in 62 patients with hepatitis B Á/C and 14.06% in 119 'high risk' hepatitis patients."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T131","span":{"begin":0,"end":139},"obj":"Sentence"}],"text":"The positive rates of anti-TTV antibodies were 11.29% in 62 patients with hepatitis B Á/C and 14.06% in 119 'high risk' hepatitis patients."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T848","span":{"begin":74,"end":83},"obj":"Phenotype"},{"id":"T849","span":{"begin":120,"end":129},"obj":"Phenotype"}],"attributes":[{"id":"A848","pred":"hp_id","subj":"T848","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A849","pred":"hp_id","subj":"T849","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"The positive rates of anti-TTV antibodies were 11.29% in 62 patients with hepatitis B Á/C and 14.06% in 119 'high risk' hepatitis patients."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2015","span":{"begin":74,"end":85},"obj":"Disease"},{"id":"T2016","span":{"begin":74,"end":83},"obj":"Disease"},{"id":"T2017","span":{"begin":88,"end":89},"obj":"Disease"},{"id":"T2018","span":{"begin":120,"end":129},"obj":"Disease"},{"id":"T51298","span":{"begin":74,"end":85},"obj":"Disease"},{"id":"T68214","span":{"begin":74,"end":83},"obj":"Disease"},{"id":"T92666","span":{"begin":120,"end":129},"obj":"Disease"}],"attributes":[{"id":"A2015","pred":"mondo_id","subj":"T2015","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A2016","pred":"mondo_id","subj":"T2016","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A2017","pred":"mondo_id","subj":"T2017","obj":"http://purl.obolibrary.org/obo/MONDO_0005688"},{"id":"A2018","pred":"mondo_id","subj":"T2018","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A31105","pred":"mondo_id","subj":"T51298","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A54822","pred":"mondo_id","subj":"T68214","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A15502","pred":"mondo_id","subj":"T92666","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"}],"text":"The positive rates of anti-TTV antibodies were 11.29% in 62 patients with hepatitis B Á/C and 14.06% in 119 'high risk' hepatitis patients."}